​

Aligos Therapeutics Ownership | Who Owns Aligos Therapeutics?

OverviewForecastRevenueFinancialsChart

Aligos Therapeutics Ownership Summary

Aligos Therapeutics is owned by 3.03% institutional investors, 10.30% insiders, and 86.67% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 4.49% of ALGS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.05% of its assets in Aligos Therapeutics shares.

ALGS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAligos Therapeutics3.03%10.30%86.67%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deep track capital, lp444.11K4.49%$3.30M
Alyeska investment group412.00K4.17%$3.06M
Sio capital management327.24K3.31%$2.43M
Marshall wace, llp267.13K2.70%$1.98M
Readystate asset management lp203.11K1.96%$1.99M
Vanguard group200.40K1.93%$1.87M
Woodline partners lp177.36K1.79%$1.32M
Summittx capital148.80K1.51%$1.11M
Adage capital partners gp140.00K1.35%$1.37M
Renaissance100.45K1.02%$746.34K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sio capital management327.24K0.35%$2.43M
Readystate asset management lp203.11K0.08%$1.99M
Deep track capital, lp444.11K0.05%$3.30M
Summittx capital148.80K0.03%$1.11M
Hhlr advisors76.25K0.03%$566.51K
Alyeska investment group412.00K0.01%$3.06M
Quest partners13.88K0.01%$129.32K
Woodline partners lp177.36K0.01%$1.32M
Baker bros. advisors lp83.06K0.00%$617.10K
Adage capital partners gp140.00K0.00%$1.37M

Top Buyers

HolderShares% AssetsChange
Readystate asset management lp203.11K0.08%66.33K
Ubs group37.06K-36.70K
Vanguard group200.40K-28.71K
Vanguard fiduciary trust28.44K0.00%28.44K
Renaissance100.45K0.00%15.01K

Top Sellers

HolderShares% AssetsChange
Armistice capital---7.26M
Ecor1 capital---6.39M
Versant venture management---1.46M
Opaleye management---1.26M
Pivotal bioventure partners investment advisor---743.22K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust28.44K0.00%28.44K$211.29K
Virtu financial12.31K0.00%12.31K$4.00K
D. e. shaw10.98K-10.98K$81.57K
Quadrature capital10.82K0.00%10.82K$80.41K
Federation des caisses desjardins du quebec950.00-950.00$7.06K

Sold Out

HolderChange
Citigroup-1.00
Qube research-2.00
Barclays-15.00
Nelson, van denburg & campbell wealth management group-80.00
Spire wealth management-200.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202610-74.36%299,603-89.34%30.41%4-80.00%2-71.43%
Dec 31, 20256-81.82%211,095-92.04%20.31%1-93.75%2-66.67%
Sep 30, 20259-75.68%395,786-85.37%30.56%6-66.67%--100.00%
Jun 30, 2025375.71%2,706,888-15.60%261.80%19-9.52%8-
Mar 31, 2025352.94%3,295,608103.61%395.89%20-9.09%8166.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv126.97K2.05%-
Vanguard US Total Market Shares ETF52.80K0.86%-
Vanguard Institutional Extnd Mkt Idx Tr46.95K0.76%-
Fidelity Extended Market Index24.90K0.40%-1.88K
Schwab US Small-Cap ETF™25.39K0.37%35.00
Fidelity Total Market Index7.55K0.12%-
Extended Equity Market Fund B6.18K0.10%-
Extended Equity Market Fund E6.18K0.10%-
Blackrock Extended Mkt Fund CF6.18K0.10%-
Fidelity Series Total Market Index6.14K0.10%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 25, 2023Nuechterlein Carole Buy$6.00M
Oct 25, 2023Nuechterlein Carole Buy$3.00M
Oct 20, 2020Novo Holdings A/S-Buy$3.00M
Oct 20, 2020Woiwode Thomas-Buy$3.00M
Oct 20, 2020Vivo Capital VIII, LLC-Buy$7.25M

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--

ALGS Ownership FAQ

Who Owns Aligos Therapeutics?

Aligos Therapeutics shareholders are primarily institutional investors at 3.03%, followed by 10.30% insiders and 86.67% retail investors. The average institutional ownership in Aligos Therapeutics's industry, Biotech Stocks , is 35.75%, which Aligos Therapeutics falls below.

Who owns the most shares of Aligos Therapeutics?

Aligos Therapeutics’s largest shareholders are Deep track capital, lp (444.11K shares, 4.49%), Alyeska investment group (412K shares, 4.17%), and Sio capital management (327.24K shares, 3.31%). Together, they hold 11.97% of Aligos Therapeutics’s total shares outstanding.

Does Blackrock own Aligos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aligos Therapeutics.

Who is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested?

Sio capital management is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.35% of its assets in 327.24K Aligos Therapeutics shares, valued at 2.43M$.

Who is the top mutual fund holder of Aligos Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aligos Therapeutics shares, with 2.05% of its total shares outstanding invested in 126.97K Aligos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools